Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study.

Gotschall, Jeromy W; Major, C Kendall; Jacobs, Linda A; Blauch, Abigail; Pucci, Donna; Palmer, Steven C; Mamtani, Ronac

Gotschall, Jeromy W; Major, C Kendall; Jacobs, Linda A; Blauch, Abigail; Pucci, Donna; Palmer, Steven C; Mamtani, Ronac.

Afiliación

Gotschall JW; Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA.
Major CK; Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA.
Jacobs LA; Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA.
Blauch A; Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA.
Pucci D; Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA.
Palmer SC; Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA.
Mamtani R; Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA.

BJUI Compass ; 4(2): 164-166, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36816152

Palabras clave

biochemical marker; bladder cancer; cotinine; cystectomy; muscle invasive bladder cancer; neoadjuvant chemotherapy; platinumbased chemotherapy; salivary cotinine; smoking; treatment efficacy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google